首页> 外文期刊>Nucleic Acids Research >Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
【24h】

Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.

机译:单链,准二聚体锌指核酸酶的开发,用于选择性降解突变的人类线粒体DNA。

获取原文
获取原文并翻译 | 示例
           

摘要

The selective degradation of mutated mitochondrial DNA (mtDNA) molecules is a potential strategy to re-populate cells with wild-type (wt) mtDNA molecules and thereby alleviate the defective mitochondrial function that underlies mtDNA diseases. Zinc finger nucleases (ZFNs), which are nucleases conjugated to a zinc-finger peptide (ZFP) engineered to bind a specific DNA sequence, could be useful for the selective degradation of particular mtDNA sequences. Typically, pairs of complementary ZFNs are used that heterodimerize on the target DNA sequence; however, conventional ZFNs were ineffective in our system. To overcome this, we created single-chain ZFNs by conjugating two FokI nuclease domains, connected by a flexible linker, to a ZFP with an N-terminal mitochondrial targeting sequence. Here we show that these ZFNs are efficiently transported into mitochondria in cells and bind mtDNA in a sequence-specific manner discriminating between two 12-bp long sequences that differ by a single base pair. Due to their selective binding they cleave dsDNA at predicted sites adjacent to the mutation. When expressed in heteroplasmic cells containing a mixture of mutated and wt mtDNA these ZFNs selectively degrade mutated mtDNA, thereby increasing the proportion of wt mtDNA molecules in the cell. Therefore, mitochondria-targeted single-chain ZFNs are a promising candidate approach for the treatment of mtDNA diseases.
机译:突变的线粒体DNA(mtDNA)分子的选择性降解是用野生型(wt)mtDNA分子重新填充细胞,从而减轻构成mtDNA疾病的线粒体功能缺陷的潜在策略。锌指核酸酶(ZFN)是与工程改造以结合特定DNA序列的锌指肽(ZFP)缀合的核酸酶,可用于选择性降解特定的mtDNA序列。通常,使用在目标DNA序列上异源二聚体的互补ZFN对。但是,传统的ZFN在我们的系统中无效。为了克服这个问题,我们通过将两个FokI核酸酶结构域(通过柔性接头连接)与具有N端线粒体靶向序列的ZFP缀合来创建单链ZFN。在这里,我们显示这些ZFN被有效地转运到细胞中的线粒体中,并以序列特异性方式结合mtDNA,以区分两个12 bp长序列,它们之间有一个碱基对。由于它们的选择性结合,它们在突变附近的预测位点切割了dsDNA。当在含有突变和wt mtDNA混合物的异质细胞中表达时,这些ZFN选择性降解突变的mtDNA,从而增加细胞中wt mtDNA分子的比例。因此,针对线粒体的单链ZFN是治疗mtDNA疾病的有前途的候选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号